Nukem Loans (“$NUKEM”) to Deploy a Lending Market for Dons (“$DONS”) Coin
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
News
Nukem Loans (“$NUKEM”) to Deploy a Lending Market for DogeBonk (“$DOBO”) Coin
RAS AL KHAIMAH, United Arab Emirates, July 17, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
A Resounding Success at the 2-Day Retail & E-commerce Summit Asia
MANILA, Jul 18, 2023 – (ACN Newswire) – In a noteworthy feat, rockbird media organized…
Wolters Kluwer named a leading global provider of ESG Software by independent research firm
Corporate Performance & ESG (CP & ESG) division recognized as having the strongest market momentum…
Avangrid’s New York Companies File Action Plan to Advance State Climate Goals
NYSEG and RG&E will play a fundamental role in ushering in New York state’s clean…
Securian Financial names Pete Berlute senior vice president of Affinity Solutions, hires Wen Nannen as chief investment officer and Mike Dominowski as head of sustainability
ST. PAUL, Minn.–(BUSINESS WIRE)–Securian Financial today named a new leader for one of its divisions…
Q2 Announces Second Philanthropy Fund Grant Cycle
Program to award $120,000 in grants to non-profits across the globe to further their mission…
Discovered Intelligence launches Aura Asset Intelligence 4.1, advancing cyber asset attack surface management using Splunk
TORONTO, July 17, 2023 (GLOBE NEWSWIRE) — Discovered Intelligence Inc., an award winning Splunk® services…
Discovered Intelligence launches Aura Asset Intelligence 4.1, advancing cyber asset attack surface management using Splunk
TORONTO, July 17, 2023 (GLOBE NEWSWIRE) — Discovered Intelligence Inc., an award winning Splunk® services…
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
CHARLOTTESVILLE, Va. and CARMEL, Ind., July 17, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ:…
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
CHARLOTTESVILLE, Va. and CARMEL, Ind., July 17, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ:…
Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants
Tel Aviv, Israel / Vancouver, Canada, July 17, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants
Tel Aviv, Israel / Vancouver, Canada, July 17, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
BALA CYNWYD, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
BALA CYNWYD, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
4DMT Completes Enrollment of Phase 2 PRISM Clinical Trial for Intravitreal 4D-150 in Patients with Wet AMD and Reports Interim Safety and Tolerability Data
Completed target enrollment of 50 patients in the randomized Phase 2 Dose Expansion stage of…
4DMT Completes Enrollment of Phase 2 PRISM Clinical Trial for Intravitreal 4D-150 in Patients with Wet AMD and Reports Interim Safety and Tolerability Data
Completed target enrollment of 50 patients in the randomized Phase 2 Dose Expansion stage of…
NysnoBio Awarded Michael J. Fox Foundation Grant to Advance Parkin Gene Therapy
– The funding will support NB001 Parkin gene replacement therapy IND-enabling studies– Initial indication in…
Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301
LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today…
The University of Texas Rio Grande Valley Selects Syntellis Performance Solutions to Streamline and Transform Financial Performance Reporting
Integrating Syntellis’ Axiom™ Higher Education Suite will accelerate informed decision-making and enhance financial planning processes…